Location History:
- Upper Arlington, OH (US) (2022)
- Scottsdale, AZ (US) (2023)
- Columbus, OH (US) (2022 - 2024)
Company Filing History:
4 out of 1,506 
1 out of 1,746 
Years Active: 2022-2024
Title: Innovations of Tanios Bekaii-Saab in Cancer Treatment
Introduction
Tanios Bekaii-Saab is a prominent inventor based in Upper Arlington, OH (US). He has made significant contributions to the field of cancer treatment, holding a total of four patents. His work focuses on innovative methods and compositions aimed at addressing critical health challenges.
Latest Patents
Among his latest patents is a method for the treatment of cancer cachexia. This patent discloses pharmaceutical compositions that include a class I/IIB HDAC inhibitor and an androgen. Specifically, the method involves administering these compounds to patients diagnosed with cancer cachexia, with the class I/IIB HDAC inhibitor identified as AR-42. Another notable patent involves human PD-1 peptide vaccines and their applications. This patent covers synthetic and chimeric PD-1 peptides, as well as anti-PD-1 antibodies, which are utilized in treating cancers, autoimmune diseases, and Alzheimer's disease.
Career Highlights
Tanios Bekaii-Saab has worked with esteemed organizations such as the Ohio State Innovation Foundation and the Mayo Foundation for Medical Education and Research. His career reflects a commitment to advancing medical science and improving patient outcomes through innovative research.
Collaborations
He has collaborated with notable colleagues, including Ching-Shih Chen and Samuel K Kulp, contributing to the development of groundbreaking treatments in oncology.
Conclusion
Tanios Bekaii-Saab's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents and collaborations highlight his dedication to improving healthcare through scientific advancements.